Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05IIN
|
||||
| Former ID |
DCL000642
|
||||
| Drug Name |
SSR125543
|
||||
| Synonyms |
SSR 125543; 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Phase 2 | [522897] | ||
| Company |
Sanofi-Aventis
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C27H28ClFN2OS
|
||||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(CC2CC2)N(CC#C)C3=NC(=C(S3)C)C4=CC(=C(C<br />=C4Cl)OC)C)F
|
||||
| InChI |
1S/C27H28ClFN2OS/c1-6-11-31(24(13-19-8-9-19)20-10-7-16(2)23(29)14-20)27-30-26(18(4)33-27)21-12-17(3)25(32-5)15-22(21)28/h1,7,10,12,14-15,19,24H,8-9,11,13H2,2-5H3/t24-/m0/s1
|
||||
| InChIKey |
IEAKXXNRGSLYTQ-DEOSSOPVSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Corticotropin releasing factor receptor 1 | Target Info | Antagonist | [549823] | |
| NetPath Pathway | TNFalpha Signaling Pathway | ||||
| PANTHER Pathway | Cortocotropin releasing factor receptor signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.